Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance, beginning of period at Dec. 31, 2019   $ 3 $ 66,503 $ (49,930)
Fair value of private warrants converted to public warrants     0  
Exercise of warrants, net of issuance costs     0  
Stock-based compensation expense     523  
Stock issued under stock compensation plan     331  
Beneficial conversion feature on convertible notes     93  
Conversion of debt to common stock     655  
Issuance of common stock, net of issuance costs   1 29,002  
Net income (loss) $ (5,620)     (5,620)
Balance, end of period at Sep. 30, 2020 41,561 4 97,107 (55,550)
Balance, beginning of period at Jun. 30, 2020   3 91,905 (53,411)
Fair value of private warrants converted to public warrants     0  
Exercise of warrants, net of issuance costs     0  
Stock-based compensation expense 221      
Stock issued under stock compensation plan     331  
Conversion of debt to common stock     655  
Issuance of common stock, net of issuance costs   1 3,995  
Net income (loss) (2,139)     (2,139)
Balance, end of period at Sep. 30, 2020 41,561 4 97,107 (55,550)
Balance, beginning of period at Dec. 31, 2020 356,044 8 414,819 (58,783)
Fair value of private warrants converted to public warrants     138,196  
Exercise of warrants, net of issuance costs     45,515  
Stock-based compensation expense     35,093  
Stock issued under stock compensation plan     2,782  
Beneficial conversion feature on convertible notes     0  
Issuance of common stock, net of issuance costs   2 (892)  
Net income (loss) (47,661)     (47,661)
Balance, end of period at Sep. 30, 2021 529,079 10 635,513 (106,444)
Balance, beginning of period at Jun. 30, 2021   9 620,808 (114,269)
Fair value of private warrants converted to public warrants     (6)  
Exercise of warrants, net of issuance costs     0  
Stock-based compensation expense     14,397  
Stock issued under stock compensation plan     316  
Beneficial conversion feature on convertible notes     0  
Issuance of common stock, net of issuance costs   1 (2)  
Net income (loss) 7,825     7,825
Balance, end of period at Sep. 30, 2021 $ 529,079 $ 10 $ 635,513 $ (106,444)